BIXINCA Trademark

Trademark Overview


On Saturday, October 24, 2015, a trademark application was filed for BIXINCA with the United States Patent and Trademark Office. The USPTO has given the BIXINCA trademark a serial number of 79179473. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, July 15, 2022. This trademark is owned by Novartis AG. The BIXINCA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
bixinca

General Information


Serial Number79179473
Word MarkBIXINCA
Filing DateSaturday, October 24, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, July 15, 2022
Registration Number5010291
Registration DateTuesday, August 2, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, September 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Monday, August 1, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, August 1, 2022DEATH OF INTERNATIONAL REGISTRATION
Monday, January 3, 2022INTERNATIONAL REGISTRATION RENEWED
Wednesday, December 22, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Tuesday, August 24, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Tuesday, August 24, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, May 22, 2020NOTIFICATION PROCESSED BY IB
Friday, May 15, 2020NOTIFICATION PROCESSED BY IB
Friday, September 20, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, September 20, 2019DEATH OF INTERNATIONAL REGISTRATION
Thursday, February 2, 2017NOTIFICATION PROCESSED BY IB
Tuesday, September 6, 2016FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 6, 2016FINAL DISPOSITION PROCESSED
Thursday, September 1, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, August 2, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 17, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 27, 2016NOTICE OF PUBLICATION
Friday, March 18, 2016NOTIFICATION PROCESSED BY IB
Friday, March 18, 2016CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, March 15, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 24, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 24, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 24, 2016NOTICE OF PUBLICATION
Wednesday, February 10, 2016ELECTRONIC RECORD REVIEW COMPLETE
Friday, February 5, 2016ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, January 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 20, 2016ASSIGNED TO EXAMINER
Saturday, January 9, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, January 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 4, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, December 30, 2015SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB